GRAIL Financial Ratios
NASDAQ: GRALHealth CareMedical SpecialitiesUSD
140.58+7.97 (+6.01%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
GRAIL ratio analysis
GRAIL earned a net margin of -277.5% in FY 2025, up from -1613.9% a year earlier. Return on equity reached -15.8%, meaning GRAIL generated -0.16 dollars of profit for every dollar of shareholders' equity. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
GRAIL financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2023 |
|---|---|---|---|---|
| Price / sales | 22.19 | 4.94 | — | — |
| Price / book | 1.27 | 0.25 | — | — |
| Operating margin | -382.0% | -1,743.0% | -1,627.6% | -9,798.2% |
| Net margin | -277.5% | -1,613.9% | -1,574.2% | -9,719.3% |
| Free cash flow margin | -203.8% | -463.7% | -653.8% | -1,051.6% |
| Return on equity (ROE) | -15.8% | -81.0% | — | — |
| Return on assets (ROA) | -14.0% | -67.9% | -37.4% | — |
| Current ratio | 11.97 | 10.66 | 0.95 | — |
| Revenue growth | 17.2% | 34.9% | 67.6% | — |